---
title: "Daclatasvir (Daklinza(r))"
ocid: "ocds-r6ebe6-0000507360"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000507360"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000507360.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000507360.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")"
published: "2017-09-28"
---

# Daclatasvir (Daklinza(r))

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")  
Current stage: Award  
OCID: ocds-r6ebe6-0000507360

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000507360)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000507360.json)

## Summary

The procurement process was initiated by The Common Services Agency, more commonly known as NHS National Services Scotland (NSS), for the supply of daclatasvir (Daklinza®) to NHS Scotland. The procurement is categorised under the health industry and took place in Edinburgh, UK, with the procurement stage being the award phase. The contract was signed on the 18th of August 2017 and falls under a limited procurement method, specifically awarded without prior publication of a call for competition due to patent protections of the medicine for the duration of the contract.

This tender presents significant opportunities for businesses specialising in pharmaceutical supplies or health-related products, especially those that focus on patented medications. Companies that manufacture or have access to daclatasvir (Daklinza®) or similar therapeutic agents would be particularly well-positioned to compete. Collaborations or partnerships within the pharmaceutical sector could also enhance competitiveness, as there is a clear emphasis on compliance with regulations and quality standards required by NHS Scotland.

## Notice

The supply of daclatasvir (Daklinza(r)) to NHS Scotland

### Lot Information

Lot 1

This procurement is for the supply of daclatasvir (Daklinza(r))to NHS Scotland.

### Procurement Information

The medicine awarded to this framework agreement is, and will continue to be, protected by patent for the duration of the framework agreement.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT296943 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 28 Sep 2017 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 18 Aug 2017 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 28 Sep 2017 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT296943
- 18 Aug 2017 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG292959

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG292959
  Daclatasvir (Daklinza(r)) - The supply of daclatasvir (Daklinza(r)) to NHS Scotland
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT296943
  Daclatasvir (Daklinza(r)) - The supply of daclatasvir (Daklinza(r)) to NHS Scotland

## Notice URLs

- http://
- http://www.nhsscotlandprocurement.scot.nhs.uk/
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000507360

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000507360. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000507360.json.